Clinical Trials Directory

Trials / Completed

CompletedNCT00228657

Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride

The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
1,100 (planned)
Sponsor
Bayside Health · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients resuscitated with 4% Albumin will have less incidence and reduced severity of pressure injuries than patients resuscitated with 0.9% Sodium Chloride due to the improved intravascular oncotic pressure effected from higher albumin levels.

Detailed description

Pressure ulcers incur multiple risks to the patient. The disruption of the skin is a portal of entry for infection , which may remain localised to the site or become blood borne. A pressure ulcer can lead to protein and fluid losses from the wound exudate. Many authors have theorised the existence of a relationship between the development of pressure ulcers and low serum albumin levels however, there is no strong evidence to prove this correlation. The literature does demonstrate a clear relationship between people with existing pressure ulcers and the presence of low serum albumins. Specifically serum albumin levels \<30mg/dl have been associated with the incidence of pressure ulcer development.

Conditions

Interventions

TypeNameDescription
DRUG4% Albumin / 0.9% Sodium Chloride

Timeline

Start date
2002-07-01
Primary completion
2003-08-01
Completion
2003-08-01
First posted
2005-09-29
Last updated
2013-11-27

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00228657. Inclusion in this directory is not an endorsement.

Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride (NCT00228657) · Clinical Trials Directory